查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1512032

胰島素注射輔助器具市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場預測，2024-2030 年

Insulin Injection Aids Market Size, Share & Trends Analysis Report By Product (Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

胰島素注射輔助器具市場成長和趨勢：

根據 Grand View Research, Inc. 的最新報告，預計到 2030 年，全球胰島素注射輔助器具市場規模將達到 3.787 億美元，2024 年至 2030 年複合年成長率將持續成長。推動胰島素注射輔助器具市場的主要因素是糖尿病盛行率的上升。此外，人們越來越偏好比傳統管瓶和注射器（例如胰島素幫浦、注射器和筆）更先進的胰島素輸送方法，也推動了市場的發展。

糖尿病盛行率的增加導致對胰島素注射輔助器具的需求增加。例如，根據 IDF 糖尿病地圖集發布的報告，到 2022 年，將有 5.37 億成年人患有糖尿病，即十分之一。預計到 2030 年，這一數字將增至 6.34 億，到 2045 年將增至 7.83 億。胰島素注射輔助器具的出現有助於準確、方便地注射胰島素，有助於更好地治療糖尿病。

此外，技術進步也是推動市場成長的因素之一。技術的進步使得能夠創建更先進和方便用戶使用的胰島素輸送系統。技術進步對胰島素注射輔助器具的開發產生了相當大的影響，以改善糖尿病患者的整體體驗。例如，為視力不佳的人開發了注射器放大鏡，透過放大注射器上的標記和數字來幫助患者讀取注射器所需的劑量。此外，由 Medtronic plc 開發的 i-Port 注射端口是一種放置在皮膚上長達三天的端口，以防止每次注射胰島素時刺穿皮膚。此外，注射器填充裝置、筆式注射器和自動注射器等注射器旨在幫助人們更好地管理糖尿病。

胰島素注射輔助器具市場報告亮點

  • 從產品來看，由於糖尿病盛行率不斷上升，注射輔助器具細分市場在 2023 年佔據了 38.77% 的市場。
  • 按最終用途分類，居家照護細分市場在 2023 年佔據主導地位，佔有率為 45.36%。便利性、個人化治療和潛在的成本節省促成了最大的市場佔有率。
  • 由於糖尿病患者的增加，北美在 2023 年的銷售佔有率方面領先市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 胰島素注射輔助器具市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 胰島素注射輔助器具市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章胰島素注射輔助器具市場：產品估算與趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 全球胰島素注射輔助器具市場：按產品分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 胰島素管瓶輔助器具市場
  • 注射器輔助器具市場
  • 噴油嘴市場
  • 兒童愛滋病市場
  • 其他市場

第5章胰島素注射輔助器具市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 全球胰島素注射輔助器具市場展望（依最終用途）
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 專科診所
  • 居家照護設置
  • 其他

第6章 胰島素注射輔助器具市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
  • 公司簡介
    • Medtronic Plc
    • Convatec Inc.
    • Becton, Dickinson and Co.
    • AmbiMedInc.
    • Medicool
    • TickleTec Ltd
    • Pain Care Labs
    • Apothecary Products
    • BIONIX LLC
    • Prodigy Diabetes Care, LLC
Product Code: GVR-4-68040-302-0

Insulin Injection Aids Market Growth & Trends:

The global insulin injection aids market size is anticipated to reach USD 378.7 million by 2030, growing at a CAGR of from 2024 to 2030, according to a new report by Grand View Research, Inc. A major factor propelling the market for insulin injection aids is the rising prevalence of diabetes. Furthermore, increasing preference for advanced insulin administration methods over conventional vials and syringes, such as insulin pumps, injectors, and pens is fueling the market.

Growing prevalence of diabetes is leading to the higher demand for the insulin injection aids. For instance, according to the report published by IDF Diabetes Atlas, in 2022, 537 Million adults had diabetes - 1 in 10. This number is expected to rise to 634 Million by 2030 and 783 Million by 2045. The availability of insulin injection aids makes it easier to administer insulin precisely and conveniently, which helps with better diabetes care.

Additionally, technological advancements are another factor driving the growth of the market. Technological advancements have enabled the creation of more advanced and user-friendly insulin delivery systems. To enhance the entire experience for individuals with diabetes, technological advancements have had a considerable impact on the development of insulin injection aids. For instance, syringe magnifiers are developed for the people with poor vision, the markings and number on the syringe are enlarged with this device to help the patients read the dosage requirements on the syringe. Moreover, I-Port Injection Port developed by Medtronic plc is a port that should be worn for up to three days on the skin to avoid skin puncture at every insulin dose. Additionally, syringe filling devices, injectors such as pen or auto injectors are designed to help people for better diabetes management.

Insulin Injection Aids Market Report Highlights:

  • Based on products, syringe aids segment dominated the market in 2023, with a share of 38.77% owing to the rising prevalence of diabetes
  • Based on end-use, home care settings segment dominated the market with a share of 45.36% in 2023. The convenience, individualized treatments, and potential cost savings contributed to its largest market share.
  • North America led the market with the maximum revenue share in 2023, owing to the increasing number of patients suffering from diabetes.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Injection Aids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of diabetes globally
      • 3.2.1.2. Growing geriatric population
      • 3.2.1.3. Growing awareness and education about diabetes management
      • 3.2.1.4. Expansion of healthcare infrastructure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness in emerging markets
      • 3.2.2.2. Poor reimbursement scenarios
  • 3.3. Insulin Injection Aids Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Insulin Injection Aids Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Insulin Injection Aids Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Insulin Vial Aids Market
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Syringe Aids Market
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Injectors Market
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Aids for Kids Market
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others Market
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Insulin Injection Aids Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Insulin Injection Aids Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospitals
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Specialty Clinics
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Home Care Settings
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Injection Aids Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Medtronic Plc
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Convatec Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Becton, Dickinson and Co.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. AmbiMedInc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Medicool
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. TickleTec Ltd
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Pain Care Labs
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Apothecary Products
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. BIONIX LLC
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Prodigy Diabetes Care, LLC
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 Global insulin injection aids market, by region 2018 - 2030 (USD Million)
  • Table 2 Global insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America insulin injection aids market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Mexico insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 12 Mexico insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe insulin injection aids market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 UK. insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 19 UK insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 23 France insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Italy insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 25 Italy insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Spain insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 27 Spain insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Denmark insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 29 Denmark insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Sweden insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 31 Sweden insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Norway insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 33 Norway insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific insulin injection aids market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Japan insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 38 Japan insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 China insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 40 China insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 India insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 42 India insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Australia insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 44 Australia insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Thailand insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 South Korea insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 48 South Korea insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America insulin injection aids market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 51 Latin America insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Brazil insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 53 Brazil insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Argentina insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 MEA insulin injection aids market, by country, 2018 - 2030 (USD Million)
  • Table 57 MEA insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 58 MEA insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Africa insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 UAE insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait insulin injection aids market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait insulin injection aids market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance
  • Table 69 Product benchmarking
  • Table 70 Strategic Initiatives

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Insulin injection aids market: Market snapshot
  • Fig. 9 Insulin injection aids market: Market segmentation
  • Fig. 10 Insulin injection aids market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Insulin injection aids market driver impact
  • Fig. 14 Insulin injection aids market restraint impact
  • Fig. 15 Insulin injection aids market porter's five forces analysis
  • Fig. 16 Insulin injection aids market PESTEL analysis
  • Fig. 17 Insulin injection aids market segment dashboard
  • Fig. 18 Insulin injection aids market: Product movement Analysis
  • Fig. 19 Insulin vial aids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Syringe aids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Injectors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Aids for kids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Insulin injection aids market: End Use movement Analysis
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Specialty Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Homecare Settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global insulin injection aids market: Regional movement analysis
  • Fig. 30 Global insulin injection aids market: Regional outlook and key takeaways
  • Fig. 31 Global market share, by Region
  • Fig. 32 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Market participant categorization
  • Fig. 62 Heat map analysis